ONWRF (Onward Medical NV) Ending Cash Position: $79.75 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ONWRF Onward Medical NV ONWRF
37 GF Score
Price $2.73
GF Value $178.62
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Onward Medical NV Ending Cash Position?

Onward Medical NV ONWRF -4.78% 37 Ending Cash Position is $79.75 Mil as of Dec. 2025. GuruFocus rates ONWRF with a GF Score™ of 37/100 and a GF Value™ of $178.62 (Possible Value Trap). The stock has 4 warning signs investors should review.

Onward Medical NV's Ending Cash Position for the quarter that ended in Dec. 2025 was $79.75 Mil.

Onward Medical NV's quarterly Ending Cash Position declined from Dec. 2024 ($62.87 Mil) to Jun. 2025 ($47.21 Mil) but then increased from Jun. 2025 ($47.21 Mil) to Dec. 2025 ($79.75 Mil).

Onward Medical NV's annual Ending Cash Position increased from Dec. 2023 ($32.46 Mil) to Dec. 2024 ($62.87 Mil) and increased from Dec. 2024 ($62.87 Mil) to Dec. 2025 ($79.75 Mil).

Onward Medical NV Ending Cash Position Related Terms

Onward Medical NV Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Onward Medical NV's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onward Medical NV Ending Cash Position Chart

Onward Medical NV Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only 101.07 44.24 32.46 62.87 79.75

Onward Medical NV Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.46 26.43 62.87 47.21 79.75
ONWRF
37GF Score
Onward Medical NV ONWRF
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onward Medical NV Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Onward Medical NV's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=70.307+9.447
=79.75

Onward Medical NV's Ending Cash Position for the quarter that ended in Dec. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=47.927+31.827
=79.75

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $79.75 Mil mean?
Onward Medical NV (ONWRF) has a Ending Cash Position of $79.75 Mil as of Dec. 2025. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Onward Medical NV and its competitors.
Is Onward Medical NV's Ending Cash Position too high?
Onward Medical NV's current Ending Cash Position is $79.75 Mil. Overall, Onward Medical NV has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Onward Medical NV's Ending Cash Position compare to VRTX and REGN?
Onward Medical NV's Ending Cash Position of $79.75 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Onward Medical NV and its competitors. Onward Medical NV's current Ending Cash Position is $79.75 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onward Medical NV stock overvalued right now?
Based on GuruFocus' analysis, Onward Medical NV (ONWRF) is currently considered Possible Value Trap. The stock's GF Value™ is $178.62, compared to a current price of $2.73 — trading 98.5% below its estimated fair value. The current Ending Cash Position is $79.75 Mil. Onward Medical NV's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Onward Medical NV (ONWRF), the current Ending Cash Position is $79.75 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Onward Medical NV (ONWRF) Overvalued in 2026?

Based on GuruFocus' analysis, Onward Medical NV stock appears to be undervalued. The current stock price of $2.73 is trading 98.5% below its estimated GF Value™ of $178.62. GuruFocus considers Onward Medical NV to be Possible Value Trap.

Key valuation signals for ONWRF:

  • Ending Cash Position: $79.75 Mil
  • GF Value™: $178.62 vs. price of $2.73 (98.5% below fair value)
  • GF Score™: 37/100 with 4 warning signs

No single metric tells the full story. See the ONWRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Onward Medical NV Business Description

Other Exchanges 63E:GermanyONWD:Belgium
Address Schimmelt 2, Eindhoven, NH, NLD, NL-5656
Onward Medical NV is developing and commercializing therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company's technology platforms are based on ONWARD ARC Therapy (ARC Therapy), targeted, programmed electrical stimulation of the spinal cord designed to restore movement, independence, and health in people with SCI.
37GF Score

Get the complete analysis for ONWRF

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.73
Price
$178.62
GF Value